REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 190 filers reported holding REPLIGEN CORP in Q1 2016. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $124,839,864 | +15.0% | 785,107 | +2.3% | 0.05% | +20.5% |
| Q2 2023 | $108,580,028 | -26.1% | 767,567 | -12.0% | 0.04% | -30.2% |
| Q1 2023 | $146,899,824 | -19.6% | 872,534 | -19.1% | 0.06% | -23.2% |
| Q4 2022 | $182,703,268 | +20.3% | 1,079,105 | +32.9% | 0.08% | +10.8% |
| Q3 2022 | $151,871,000 | -19.4% | 811,669 | -30.1% | 0.07% | -14.0% |
| Q2 2022 | $188,463,000 | -21.9% | 1,160,484 | -9.6% | 0.09% | -7.5% |
| Q1 2022 | $241,430,000 | -12.5% | 1,283,585 | +23.2% | 0.09% | -5.1% |
| Q4 2021 | $276,016,000 | -16.2% | 1,042,199 | -8.5% | 0.10% | -24.6% |
| Q3 2021 | $329,309,000 | +30.2% | 1,139,518 | -10.0% | 0.13% | +27.5% |
| Q2 2021 | $252,845,000 | +15.9% | 1,266,630 | +12.9% | 0.10% | +6.2% |
| Q1 2021 | $218,129,000 | +4.9% | 1,122,006 | +3.4% | 0.10% | -2.0% |
| Q4 2020 | $208,020,000 | +24.7% | 1,085,527 | -4.0% | 0.10% | +8.9% |
| Q3 2020 | $166,849,000 | -1.0% | 1,130,873 | -17.1% | 0.09% | -9.1% |
| Q2 2020 | $168,609,000 | +78.0% | 1,364,041 | +39.0% | 0.10% | +45.6% |
| Q1 2020 | $94,710,000 | +523.5% | 981,043 | +497.4% | 0.07% | +655.6% |
| Q4 2019 | $15,190,000 | +27.7% | 164,221 | +5.9% | 0.01% | +28.6% |
| Q3 2019 | $11,892,000 | +18.3% | 155,071 | +32.6% | 0.01% | +16.7% |
| Q2 2019 | $10,050,000 | +82.4% | 116,931 | +25.4% | 0.01% | +50.0% |
| Q1 2019 | $5,509,000 | +6.0% | 93,241 | -5.4% | 0.00% | 0.0% |
| Q4 2018 | $5,197,000 | +50.3% | 98,541 | +58.1% | 0.00% | +100.0% |
| Q3 2018 | $3,457,000 | +17.9% | 62,330 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $2,932,000 | +50.0% | 62,330 | +15.4% | 0.00% | +100.0% |
| Q1 2018 | $1,955,000 | +3.4% | 54,030 | +3.6% | 0.00% | 0.0% |
| Q4 2017 | $1,891,000 | -5.4% | 52,130 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $1,998,000 | -37.8% | 52,130 | -32.7% | 0.00% | -50.0% |
| Q2 2017 | $3,210,000 | +78.0% | 77,460 | +51.2% | 0.00% | +100.0% |
| Q1 2017 | $1,803,000 | -45.8% | 51,230 | -52.6% | 0.00% | -66.7% |
| Q4 2016 | $3,329,000 | -17.8% | 108,000 | -19.5% | 0.00% | 0.0% |
| Q3 2016 | $4,050,000 | +54.2% | 134,160 | +39.8% | 0.00% | +50.0% |
| Q2 2016 | $2,626,000 | +47.9% | 95,980 | +45.0% | 0.00% | 0.0% |
| Q1 2016 | $1,775,000 | +13.1% | 66,190 | +19.3% | 0.00% | +100.0% |
| Q4 2015 | $1,569,000 | +2.0% | 55,460 | +0.4% | 0.00% | 0.0% |
| Q3 2015 | $1,538,000 | -32.6% | 55,230 | -0.1% | 0.00% | -50.0% |
| Q2 2015 | $2,282,000 | +47.7% | 55,300 | +8.6% | 0.00% | +100.0% |
| Q1 2015 | $1,545,000 | +53.3% | 50,900 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $1,008,000 | -0.5% | 50,900 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $1,013,000 | -12.7% | 50,900 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $1,160,000 | +362.2% | 50,900 | +161.0% | 0.00% | – |
| Q1 2014 | $251,000 | +617.1% | 19,500 | +650.0% | 0.00% | – |
| Q4 2013 | $35,000 | -55.1% | 2,600 | -62.9% | 0.00% | – |
| Q3 2013 | $78,000 | -3.7% | 7,000 | -28.4% | 0.00% | – |
| Q2 2013 | $81,000 | – | 9,773 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 12 West Capital Management LP | 1,021,641 | $295,244,000 | 13.47% |
| Ally Bridge Group (NY) LLC | 70,000 | $20,229,000 | 5.95% |
| Miura Global Management | 85,000 | $24,564,000 | 3.81% |
| Conestoga Capital Advisors, LLC | 871,390 | $251,823,000 | 3.48% |
| Ranger Investment Management | 187,723 | $54,250,000 | 2.90% |
| AWM Investment Company, Inc. | 100,000 | $28,899,000 | 2.84% |
| Brown Capital Management | 1,017,477 | $294,041,000 | 2.41% |
| Stephens Investment Management Group LLC | 558,287 | $161,339,000 | 2.19% |
| Yorktown Management & Research Co Inc | 10,050 | $2,904,000 | 2.18% |
| SV Health Investors, LLC | 14,541 | $4,203,000 | 2.06% |